Stock Events

Stock Events

Alvotech 

$0.2201
20
+$0.02+11.16% Friday 17:04

Statistics

Day High
0.2201
Day Low
0.2201
52W High
0.23
52W Low
0.2201
Volume
1,502
Avg. Volume
-
Mkt Cap
74.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.47
-0.3
-0.14
0.03
Expected EPS
-0.032897
Actual EPS
N/A

Financials

10.11%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
276.27MRevenue
27.92MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 6.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
0%
Sell
33%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALVOW. It's not an investment recommendation.
NVIDIA
7
NVDA
Apple
6
AAPL
Meta Platforms
6
META
Tesla
5
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotechnology company focused on developing novel therapeutics, including biosimilars, which directly competes with Alvotech's biosimilar product portfolio.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a global pharmaceutical company with a strong presence in the biosimilars market, making it a direct competitor to Alvotech in the biosimilar space.
Biogen
BIIB
Mkt Cap31B
Biogen has a focus on biologics and has ventured into the biosimilars market, positioning it as a competitor to Alvotech.
Novartis
NVS
Mkt Cap286.78B
Novartis, through its generics division Sandoz, is a leading company in the biosimilars market, competing with Alvotech in developing and marketing biosimilar products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, including biosimilars, competing with Alvotech in the biosimilar pharmaceuticals market.
Merck
MRK
Mkt Cap335.14B
Merck & Co., known as MSD outside the United States and Canada, has made strides in biosimilars, making it a competitor to Alvotech.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie has a growing interest in biosimilars, particularly with its Humira biosimilar, directly competing with Alvotech's biosimilar development efforts.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its Genentech unit, is involved in the development of biosimilars, competing with Alvotech in the biotechnology and biosimilars market.
Sanofi
SNY
Mkt Cap104.76B
Sanofi is expanding its presence in the biosimilars market, making it a competitor to Alvotech in the development and commercialization of biosimilar products.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is involved in biopharmaceuticals and has shown interest in biosimilars, positioning it as a competitor to Alvotech in the biosimilar and biologics market.

About

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Show more...
CEO
Lisa Graver
Employees
1460
Country
Luxembourg
ISIN
LU2458333858

Listings

ST
SE
ALVO-SDB.ST
STU
DE
Z45.STU
XNAS
US
ALVOW
MU
DE
Z45.MU

0 Comments

Share your thoughts

FAQ

What is Alvotech stock price today?▼
The current price of ALVOW is $0.22 USD — it has increased by +11.16% in the past 24 hours. Watch Alvotech stock price performance more closely on the chart.
What is Alvotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Alvotech stocks are traded under the ticker ALVOW.
What is Alvotech market cap?▼
Today Alvotech has the market capitalization of 74.44M
When is the next Alvotech earnings date?▼
Alvotech is going to release the next earnings report on November 11, 2026.
What were Alvotech earnings last quarter?▼
ALVOW earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.05 USD resulting in a -74.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alvotech revenue for the last year?▼
Alvotech revenue for the last year amounts to 276.27M USD.
What is Alvotech net income for the last year?▼
ALVOW net income for the last year is 27.92M USD.
How many employees does Alvotech have?▼
As of August 23, 2026, the company has 1,460 employees.
In which sector is Alvotech located?▼
Alvotech operates in the Health & Wellness sector.
When did Alvotech complete a stock split?▼
Alvotech has not had any recent stock splits.
Where is Alvotech headquartered?▼
Alvotech is headquartered in Luxembourg, Luxembourg.